The Pains of Change
Pharma and biotech companies, with the rest of the healthcare industry, must face change.
QbD and PAT in Upstream and Downstream Processing
Industry experts discuss the implementation of QbD and PAT tools in biopharmaceutical manufacturing.
EU Battles Medicine Shortages
European governments are under pressure to take regulatory action, but solving the problem of medicine shortages is not as straightforward as it seems.
Outsourced Training: A Primer
Five key attributes to look for in a biopharm training partner.
Report from Brazil
Brazil offers opportunities and challenges for global pharmaceutical companies.
What Happened to Outsourcing in Asia?
The industry may not be ready for India and China as regulatory issues emerge.
Essentials in Stability Analysis and Expiry Determination
The author discusses the need for stability analysis.
Kinetic Analysis of Antibodies from Different Cultured Media
An analytical method assesses the effects of media condition on cultured antibodies.
FDA Urges Greater Focus on Contractor Quality
Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.
IPO Market Heats Up for Life-Sciences Companies
Biotech companies raise most money in 13 years.
Quality by Design: A CMO's Perspective on Gaining Knowledge Faster and Better
Traditional project decision-making vs. a QbD approach.
BioPharm International, July 2013 Issue (PDF)
Click the title above to open the BioPharm International July 2013 issue in an interactive PDF format.
